To hear about similar clinical trials, please enter your email below
Trial Title:
Jacobson's Progressive Muscle Relaxation Technique on Children With Leukemia Undergoing Chemotherapy.
NCT ID:
NCT06631196
Condition:
Leukemia
Children
Fatigue Related to Cancer Treatment
Anxiety
Conditions: Official terms:
Leukemia
Fatigue
Anxiety Disorders
Conditions: Keywords:
Jacobson's Progressive Muscle Relaxation Technique
Anxiety
Fatigue
Children
Leukemia
Chemotherapy
nursing care
Study type:
Interventional
Study phase:
N/A
Overall status:
Not yet recruiting
Study design:
Allocation:
Randomized
Intervention model:
Parallel Assignment
Primary purpose:
Supportive Care
Masking:
Single (Participant)
Intervention:
Intervention type:
Procedure
Intervention name:
Jacobson's PMRT
Description:
each child in the intervention group will perform five sessions of Jacobson's PMRT. Each
session lasted for 15-20 minutes under the supervision of the researcher.
Arm group label:
Interventional group (Jacobson's PMRT)
Summary:
The goal of this clinical trial is to determine the effect of Jacobson's progressive
muscle relaxation technique on anxiety and fatigue among children with leukemia
undergoing chemotherapy. The main research hypotheses are;
- Children with leukemia who receive Jacobson's progressive muscle relaxation
technique exhibit less anxiety than those who don't receive it.
- Children with leukemia who receive Jacobson's progressive muscle relaxation
technique exhibit less fatigue than those who don't receive it.
Researchers will compare Jacobson's progressive muscle relaxation technique with
standardized nursing care on a child's anxiety and fatigue.
Criteria for eligibility:
Criteria:
Inclusion Criteria:
- Children diagnosed with leukemia and received chemotherapy sessions.
- Age ranged from 7 to 15 years.
Exclusion Criteria:
- other disorders such as neurological diseases, cerebrovascular accidents, or mental
illness.
Gender:
All
Minimum age:
7 Years
Maximum age:
15 Years
Healthy volunteers:
Accepts Healthy Volunteers
Start date:
November 1, 2024
Completion date:
November 30, 2025
Lead sponsor:
Agency:
Alexandria University
Agency class:
Other
Source:
Alexandria University
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT06631196
